Reviewing TREES (OTCMKTS:CANN) and ResMed (NYSE:RMD)

TREES (OTCMKTS:CANN) and ResMed (NYSE:RMD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings.

Profitability

This table compares TREES and ResMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TREES	N/A	N/A	N/A
ResMed	27.44%	25.35%	18.69%

Insider and Institutional Ownership

11.3% of TREES shares are held by institutional investors. Comparatively, 55.0% of ResMed shares are held by institutional investors. 45.0% of TREES shares are held by company insiders. Comparatively, 0.7% of ResMed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

TREES has a beta of -0.45, meaning that its share price is 145% less volatile than the S&P 500. Comparatively, ResMed has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for TREES and ResMed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TREES	0	0	0	0	0.00
ResMed	0	5	9	1	2.73

ResMed has a consensus target price of $286.18, indicating a potential upside of 38.37%. Given ResMed’s stronger consensus rating and higher probable upside, analysts plainly believe ResMed is more favorable than TREES.

Valuation & Earnings

This table compares TREES and ResMed”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TREES	$13.66 million	0.26	-$3.48 million	($0.02)	-1.53
ResMed	$5.15 billion	5.85	$1.40 billion	$10.37	19.94

ResMed has higher revenue and earnings than TREES. TREES is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Summary

ResMed beats TREES on 14 of the 15 factors compared between the two stocks.

About TREES

Trees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.